Related Experiment Video
Updated: Jul 18, 2026

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
Published on: March 6, 2018
Instrumental treatments for benign prostatic obstruction
1Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Purpose Of Review:
The need to treat increasing numbers of patients with symptomatic benign prostatic obstruction has led to the continuous development of various novel or modified instrumental procedures with minimal invasiveness. The aim of the following review is to provide an overview of the current research focused on the complications and morbidity of instrumental treatment options for symptomatic benign prostatic obstruction.
Recent Findings:
A systematic Medline database search, over the past 12 months of the literature with a focus on articles about surgical treatment for benign prostatic obstruction or benign prostatic hyperplasia, provided some interesting new data concerning laser prostatectomy (holmium laser enucleation of the prostate and photoselective vaporization of the prostate) and transurethral resection of the prostate using bipolar electrocautery systems available for the review.
Summary:
The data of this review period confirmed a favorable safety profile of holmium laser enucleation of the prostate for treating patients with comorbidities. Photoselective vaporization of the prostate seems to be an efficient technique with a favorable safety profile. Its long-term potential, however, has to be confirmed by randomized controlled studies. Transurethral resection of the prostate using bipolar electrocautery systems appears to offer the advantages of improved hemostasis and the ability to avoid transurethral resection syndrome. More randomized comparisons, however, need to be undertaken before an accurate general picture is available.
Related Concept Videos
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Urinary Tract Calculi VI: Surgical Management
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Antihypertensive Drugs: Vasodilators
